TP53 and cancer: Therefore, core compounds were cytotoxic to cancer cells partly through a p53-dependent mechanism; however, loss of p53 did not completely rescue cells from the cytotoxic effects of core compounds suggesting that compounds may target both p53-dependent and p53-independent pathways.